Study guide
7.4 Trial of Labor After Cesarean (TOLAC) & Vaginal Birth After Cesarean (VBAC)
NCC Inpatient Obstetric Nursing RNC-OB
Track your progress as you read
Finished sections get a check mark.
1 Chapter 0: Introduction & How to Use This Guide
0.1 About the RNC-OB Credential & Exam Blueprint 0.2 How to Use This Study Guide & Clinical Learning Methodology
2 Chapter 1: Pregnancy Complications — Maternal Medical Conditions
1.1 Hypertensive Disorders of Pregnancy 1.2 HELLP Syndrome & Hepatic Disorders of Pregnancy 1.3 Diabetes Mellitus in Pregnancy 1.4 Maternal Cardiac and Respiratory Disorders 1.5 Infectious Diseases in Inpatient Obstetrics 1.6 Hematologic, Endocrine, Connective Tissue & Other Systemic Disorders
3 Chapter 2: Pregnancy Complications — Preterm Labor, Multiple Gestation, Placental & Fetal Disorders
2.1 Psychosocial Disorders, Substance Use & Environmental Exposures 2.2 Preterm Labor: Assessment, Tocolysis & Neuroprotection 2.3 Multiple Gestation: Placentation, Chorionicity & Complications 2.4 Placental Disorders: Previa, Abruption, Vasa Previa & PAS 2.5 Fetal Growth Disorders & Amniotic Fluid Complications
4 Chapter 3: Antenatal Fetal Assessment & Surveillance
3.1 Antenatal Testing Methods & Indications for Fetal Surveillance 3.2 Nonstress Test (NST), Contraction Stress Test (CST) & Biophysical Profile (BPP) 3.3 Diagnostic Prenatal Procedures (Amniocentesis, CVS, PUBS, cfDNA & Ultrasound) 3.4 Fetal Oxygenation Physiology & Acid-Base Regulation 3.5 Umbilical Cord Blood Gas Collection & Clinical Interpretation
5 Chapter 4: Fetal Assessment & Electronic Fetal Monitoring (EFM)
4.1 NICHD Electronic Fetal Monitoring Terminology & Baseline Features 4.2 FHR Decelerations, Acceleration Patterns & Uterine Activity 4.3 The NICHD Three-Tier Fetal Heart Rate Classification System 4.4 Intrauterine Resuscitation & Clinical Action Protocols 4.5 Fetal Arrhythmias, Dysrhythmias & Artifact Differentiation
6 Chapter 5: Labor & Birth Physiology — Mechanics, Cardinal Movements, Stages & Support
5.1 Physiology of Labor & Uterine Mechanics 5.2 Pelvic Anatomy, Fetal Lie, Presentation & Cardinal Movements of Labor 5.3 Stages of Labor, Cervical Dilatation Dynamics & Progression Guidelines 5.4 Intrapartum Admission Assessment, Obstetric Triage & Membrane Rupture Evaluation 5.5 Labor Support, Non-Pharmacologic Pain Management & Physiologic Birth Practices
7 Chapter 6: Labor & Birth Interventions — Cervical Ripening, Induction, Pain Management & Anesthesia
6.1 Bishop Scoring, Pre-Induction Cervical Ripening & Mechanical Methods 6.2 Oxytocin Administration, Titration Protocols & Uterine Tachysystole Management 6.3 Nonpharmacologic Comfort & Labor Pain Management Strategies 6.4 Systemic Opioid Analgesia & Inhaled Nitrous Oxide 6.5 Neuraxial Analgesia, Spinal/Epidural Complications & General Anesthesia
8 Chapter 7: Labor & Birth — Operative Deliveries, TOLAC/VBAC & Special Intrapartum Procedures
7.1 External Cephalic Version (ECV) & Malpresentation Management 7.2 Operative Vaginal Delivery: Vacuum Extraction & Forceps-Assisted Birth 7.3 Cesarean Delivery: Surgical Indications, Intraoperative Management & PACU Recovery 7.4 Trial of Labor After Cesarean (TOLAC) & Vaginal Birth After Cesarean (VBAC) 7.5 Special Intrapartum Procedures: Amniotomy, Amnioinfusion, Cervical Ripening & Labor Augmentation
9 Chapter 8: Obstetric Emergencies & Critical Care
8.1 Shoulder Dystocia Management & HELPERR Protocol 8.2 Umbilical Cord Prolapse & Feto-Vascular Emergencies 8.3 Uterine Rupture & Acute Uterine Inversion 8.4 Amniotic Fluid Embolism (Anaphylactoid Syndrome of Pregnancy) 8.5 Intraamniotic Infection (Chorioamnionitis) & Maternal Sepsis
10 Chapter 9: Postpartum Physiology & Immediate Recovery Care
9.1 Postpartum Physiologic Changes & Maternal Systemic Adaptations 9.2 Fourth Stage of Labor & Immediate Recovery Care 9.3 Routine Postpartum Nursing Assessment & Clinical Care (BUBBLE-HE) 9.4 Rh Isoimmunization, Alloimmunization & Postpartum Immunizations 9.5 Postpartum Discharge Teaching, Warning Signs & Maternal Safety
11 Chapter 10: Postpartum Adaptation, Hemorrhage & Clinical Complications
10.1 Postpartum Hemorrhage: Definition, Risk Stratification, 4 Ts, QBL & Pharmacotherapy 10.2 Postpartum Infections: Endometritis, Wound Infections, Sepsis & Postpartum Pyrexia 10.3 Thromboembolic Disorders: DVT, Pulmonary Embolism & Septic Pelvic Thrombophlebitis 10.4 Perinatal Mood & Anxiety Disorders: Postpartum Blues, PPD, Anxiety & Postpartum Psychosis 10.5 Lactation Physiology, Breastfeeding Complications, Engorgement & Medication Safety
12 Chapter 11: Newborn Care, Transition & Clinical Assessment
11.1 Neonatal Physiologic Transition & Cardiorespiratory Adaptation 11.2 Immediate Newborn Care, Apgar Scoring & Delivery Room Stabilization 11.3 Newborn Thermoregulation & Pathophysiology of Cold Stress 11.4 Gestational Age & Neonatal Growth Assessment 11.5 Comprehensive Newborn Head-to-Toe Examination & Normal Variants
13 Chapter 12: Newborn Complications, Resuscitation & High-Acuity Management
12.1 Neonatal Resuscitation Program (NRP 8th Edition) & Delivery Room Resuscitation 12.2 Neonatal Glucose Homeostasis, Hypoglycemia Screening & Clinical Management 12.3 Neonatal Hyperbilirubinemia, Bilirubin Metabolism & Phototherapy Protocols 12.4 Neonatal Respiratory Distress: TTN, RDS, Meconium Aspiration & Persistent Pulmonary Hypertension (PPHN) 12.5 Neonatal Sepsis, Congenital Infections & Neonatal Abstinence Syndrome (NAS/NOWS)
14 Chapter 13: Professional Practice, Legal-Ethical Frameworks, Patient Safety & Quality Improvement
13.1 Legal Aspects of Perinatal Nursing & High-Risk Documentation Standards 13.2 Ethical Principles in Perinatal Care & Maternal-Fetal Conflicts 13.3 Quality Improvement, Perinatal Safety Initiatives & AIM Bundles 13.4 Patient Safety Culture, Team Communication & Clinical Escalation 13.5 Evidence-Based Practice, Research Utilization & Perinatal Guidelines
7.4 Trial of Labor After Cesarean (TOLAC) & Vaginal Birth After Cesarean (VBAC)
Key Takeaways Explain This Topic AI
A Trial of Labor After Cesarean (TOLAC) achieves a successful Vaginal Birth After Cesarean (VBAC) rate of 60% to 80%; successful VBAC is associated with lower maternal morbidity than elective repeat cesarean delivery (ERCD), whereas failed TOLAC requiring intrapartum cesarean carries the highest morbidity.
Ideal TOLAC candidates have one prior low-transverse uterine incision, a clinically adequate pelvis, no history of uterine rupture or extensive transmural surgery, and continuous access to an obstetric provider and anesthesia capable of managing emergent delivery.
Absolute contraindications to TOLAC include a prior classical or T-shaped uterine incision, prior extensive transmural uterine surgery entering the endometrial cavity (e.g., transmural myomectomy), prior uterine rupture, and standard contraindications to vaginal delivery (placenta previa, transverse lie).
Prostaglandins (Misoprostol / PGE1 and Dinoprostone / PGE2) are strictly contraindicated for cervical ripening in patients with a scarred uterus due to a high risk of uterine rupture; mechanical methods (Foley/Cook balloon catheter) are the ripening modality of choice.
The most consistent, earliest, and reliable clinical sign of acute uterine rupture during labor is an abnormal fetal heart rate pattern (prolonged deceleration, sudden severe bradycardia, or recurrent late decelerations), occurring in up to 70% to 90% of rupture events.
Last updated: August 2026
Clinical Foundations & Contemporary Practice Guidelines
Trial of Labor After Cesarean (TOLAC) refers to a planned attempt to labor by a patient who has previously undergone a cesarean delivery, with the clinical objective of achieving a Vaginal Birth After Cesarean (VBAC) . According to national clinical consensus guidelines established by the American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM), attempting a TOLAC is a safe, appropriate, and evidence-based option for the majority of patients with a prior low-transverse cesarean delivery.
In contemporary obstetric practice, the overall success rate for patients undergoing a TOLAC is between 60% and 80% . Understanding the balance of clinical risks and benefits across delivery pathways is essential for shared decision-making:
Successful VBAC: Associated with the lowest overall maternal morbidity —less blood loss, lower transfusion rates, lower infection risk, shorter hospital stays, faster physical recovery, and avoidance of multiple hysterotomy scars that predispose to Placenta Accreta Spectrum (PAS) in future pregnancies.
Elective Repeat Cesarean Delivery (ERCD): Carries predictable, intermediate surgical risks (blood loss, infection, visceral adhesions, surgical injury, and increased risk of abnormal placentation in subsequent pregnancies).
Failed TOLAC (Unplanned Intrapartum Cesarean): Associated with the highest maternal morbidity , including higher rates of uterine rupture, operative complications, blood transfusions, endometritis, and maternal intensive care admissions. +-------------------------------------------------------------------------------------------------------------------+
| MATERNAL MORBIDITY SPECTRUM IN CESAREAN MANAGEMENT |
+-------------------------------------------------------------------------------------------------------------------+
- LOWEST MORBIDITY HIGHEST MORBIDITY
- ◄─────────────────────────────────────────────────────────────────────────────────────────────────────►
- [ Successful VBAC ] [ Elective Repeat Cesarean (ERCD) ] [ Failed TOLAC ]
- Lowest blood loss • Intermediate blood loss • Highest blood loss
- Lowest infection rate • Planned surgical risks • Highest infection rate
- Rapid recovery • Adhesions & future PAS risk • Highest rupture risk
+-------------------------------------------------------------------------------------------------------------------+
Candidate Selection, Predictors & Contraindications
Careful candidate selection is the cornerstone of safe TOLAC management. Clinicians must evaluate prior surgical documentation and clinical history to stratify individual risk. +-------------------------------------------------------------------------------------------------------------------+
| CANDIDACY SELECTION MATRIX FOR TOLAC / VBAC |
+-------------------------------------------------------------------------------------------------------------------+
CANDIDATE CATEGORY CLINICAL PROFILE & CRITERIA TOLAC ELIGIBILITY & SAFETY
--------------------- ------------------------------------------------------- -----------------------------------
- IDEAL CANDIDATES • One prior Low-Transverse Cesarean Delivery (LTCD) • Highly Favorable
- Prior successful vaginal delivery (especially VBAC) • Success rate 70% to 90%
- Clinically adequate pelvis / Spontaneous labor onset • Uterine rupture risk ~0.5% to 0.9%
--------------------- ------------------------------------------------------- -----------------------------------
- ACCEPTABLE • Two prior low-transverse cesarean deliveries • Acceptable candidates
- CANDIDATES • Twin gestation (vertex/vertex at term) • Rupture risk ~0.9% to 1.8%
- Unknown prior scar type (unless high suspicion of • Requires informed consent and
- classical incision, e.g., extreme preterm breech) experienced obstetric surgical team
- Mild fetal macrosomia (<4,500 g) without diabetes
--------------------- ------------------------------------------------------- -----------------------------------
- ABSOLUTE • Prior CLASSICAL or T-SHAPED uterine incision • STRICTLY CONTRAINDICATED
- CONTRAINDICATIONS • Prior extensive transmural uterine surgery • Catastrophic rupture risk (4% to 10%+)
- (e.g., myomectomy entering the endometrial cavity) • Requires scheduled repeat cesarean
- Previous uterine rupture at 36 0/7 to 37 0/7 weeks
- Inability to perform emergent cesarean (no OR/anesthesia)
+-------------------------------------------------------------------------------------------------------------------+
Clinical Predictors of TOLAC Success vs. Failure
Factors Significantly Increasing VBAC Success:
Prior Vaginal Delivery: The single strongest clinical predictor of success. A patient with a prior successful vaginal delivery—especially a prior successful VBAC —has an expected success rate exceeding 85% to 90% , with a significantly reduced rate of uterine rupture.
Non-Recurring Indication for Prior Cesarean: Indications such as breech presentation, twin gestation, non-reassuring fetal heart rate pattern, or placenta previa carry much higher success rates (>80%) compared to labor arrest.
Spontaneous Labor Onset: Spontaneous labor onset without need for pharmacologic induction.
Favorable Cervical Status: Advanced cervical dilatation and effacement (Bishop score >=8) upon admission.
Factors Decreasing VBAC Success / Increasing Rupture Risk:
Recurring Indication for Prior Cesarean: Labor dystocia, cephalopelvic disproportion (CPD), or active phase arrest during the previous pregnancy (success rate ~50% to 60%).
Labor Induction / Augmentation: Need for cervical ripening or high-dose oxytocin titration.
Maternal Demographics: Advanced maternal age (>=35 years), elevated pre-pregnancy BMI (>=30 to 40 kg/m²), and excessive gestational weight gain.
Interdelivery Interval <18 to 24 Months: A short interval between deliveries limits complete myometrial extracellular matrix remodeling and tensile scar healing, doubling the baseline uterine rupture risk.
Fetal Factors: Gestational age >40 weeks and estimated fetal weight >4,000 to 4,500 grams.
Intrapartum Management: Induction, Augmentation & Monitoring
Managing labor in a patient undergoing a TOLAC requires strict adherence to evidence-based safety protocols to maximize progress while safeguarding myometrial integrity. +-------------------------------------------------------------------------------------------------------------------+
| TOLAC INTRAPARTUM MANAGEMENT PROTOCOL |
+-------------------------------------------------------------------------------------------------------------------+
[ 1. CERVICAL RIPENING PROTOCOL ]
• PROSTAGLANDINS (Misoprostol / PGE1 & Dinoprostone / PGE2) ARE STRICTLY CONTRAINDICATED.
- Prostaglandins induce hyperstimulation, collagen breakdown, and catastrophic scar disruption (rupture rate >2-3%).
• MECHANICAL METHODS ARE THE RIPENING MODALITY OF CHOICE:
- Transcervical Foley balloon catheter (30 to 60 mL sterile water inflation).
- Safe, effective, and does NOT increase uterine rupture risk.
[ 2. OXYTOCIN INDUCTION & AUGMENTATION ]
- May be used with caution; requires conservative, structured titration protocols.
- Avoid excessive dosing; strict avoidance of UTERINE TACHYSYSTOLE (>5 contractions in 10 minutes).
- Maintain low-to-moderate infusion rates to achieve adequate labor progress (200-250 MVUs) without hypertonus.
[ 3. CONTINUOUS ELECTRONIC FETAL MONITORING (EFM) ]
- Continuous EFM is MANDATORY from the onset of active labor / admission throughout delivery.
- Intermittent auscultation is STRICTLY INSUFFICIENT for TOLAC.
[ 4. REGIONAL NEURAXIAL ANALGESIA ]
- Epidural analgesia is SAFE and HIGHLY RECOMMENDED for TOLAC patients.
• Does NOT mask the signs of uterine rupture (breakthrough pain of rupture is severe visceral peritoneal pain
that penetrates effective epidural sensory block).
• Facilitates rapid conversion to surgical anesthesia if emergent laparotomy becomes necessary.
+-------------------------------------------------------------------------------------------------------------------+
Uterine Rupture: Pathophysiology, Clinical Manifestations & Emergency Management
Uterine rupture is the complete anatomical separation of all layers of the uterine wall (endometrium, myometrium, and overlying serosa/visceral peritoneum), frequently accompanied by extrusion of the fetus, umbilical cord, and placenta into the maternal peritoneal cavity. +-------------------------------------------------------------------------------------------------------------------+
| UTERINE SCAR DEHISCENCE VS. TRUE UTERINE RUPTURE |
+-------------------------------------------------------------------------------------------------------------------+
FEATURE UTERINE SCAR DEHISCENCE (Uterine Window) TRUE UTERINE RUPTURE (Catastrophic)
---------------------- ----------------------------------------------- ------------------------------------------
- Peritoneal Serosa INTACT (Visceral peritoneum intact over scar) DISRUPTED (Complete transmural separation)
- Fetal Extrusion Absent (Fetus remains entirely intrauterine) Present (Fetus / placenta in peritoneum)
- Hemorrhage Minimal to absent Massive intra-abdominal hemorrhage
- Fetal Heart Rate Normal / Non-compromised Severe bradycardia / Prolonged decels
- Clinical Action Incidental finding during cesarean; no repair EMERGENCY LAPAROTOMY / RESUSCITATION
+-------------------------------------------------------------------------------------------------------------------+
Clinical Manifestations of Uterine Rupture +-------------------------------------------------------------------------------------------------------------------+
| CARDINAL CLINICAL SIGNS OF ACUTE UTERINE RUPTURE |
+-------------------------------------------------------------------------------------------------------------------+
- 1. ABNORMAL FETAL HEART RATE TRACING (The Earliest & Most Common Sign — Present in 70% to 90% of Cases)
- Sudden, severe, prolonged fetal bradycardia (<90-100 bpm) or recurrent, deep, late/variable decelerations
- Sudden loss of baseline FHR variability
- 2. SUDDEN CESSATION OF CONTRACTIONS / LOSS OF UTERINE RESTING TONE
- Uterine contractions abruptly stop or diminish in amplitude; IUPC records loss of baseline resting pressure
- 3. SEVERE, SUDDEN, UNREMITTING ABDOMINAL PAIN (Breakthrough Pain)
- Sharp, tearing, excruciating lower abdominal or suprapubic pain persisting between contractions
- Pain persists despite a fully functioning, dense epidural sensory block
- 4. LOSS OF FETAL STATION / REGRESSION OF THE PRESENTING PART
- Fetal presenting part that was deeply engaged (e.g., station +2) suddenly recedes and floats out of pelvis
- 5. PALPABLE FETAL PARTS ON ABDOMINAL EXAMINATION
- Fetal limbs or head easily palpated directly beneath maternal abdominal skin outside the contracted uterus
- 6. MATERNAL HEMODYNAMIC COLLAPSE & SHOCK
- Maternal hypotension, tachycardia, diaphoresis, pallor, syncope, and hemoperitoneum
- Vaginal bleeding may be present (variable; often minimal if blood accumulates entirely intra-abdominally)
+-------------------------------------------------------------------------------------------------------------------+
Emergency Nursing Interventions for Suspected Uterine Rupture
When acute uterine rupture is suspected, immediate interprofessional action is mandatory to prevent maternal-fetal mortality:
Declare Obstetric Emergency: Call a STAT emergency code for immediate cesarean delivery. Alert the obstetrician, operating room scrub team, anesthesiologist, and Neonatal Resuscitation Program team.
Discontinue Uterotonics: Immediately stop oxytocin infusions if running.
Maternal Resuscitation & Oxygenation: Place patient in a lateral tilt position. Administer high-flow supplemental oxygen (10 L/min via non-rebreather mask).
Aggressive Vascular Access & Volume Expansion: Ensure two large-bore IV lines (16- or 18-gauge) . Rapidly infuse isotonic crystalloids (Lactated Ringer's) to support cardiac output.
Blood Bank Mobilization: Activate the hospital Massive Transfusion Protocol (MTP) and obtain emergency uncrossmatched O-negative packed red blood cells or crossmatched units.
Immediate Transfer to Surgical Suite: Rapidly transport the patient directly to the operating room for emergent exploratory laparotomy, fetal delivery, and surgical repair of the hysterotomy rupture or emergency peripartum hysterectomy.